Straight from the Desk

Syz the moment

Live feeds, charts, breaking stories, all day long.

10 Jul 2026

Healthcare Stocks just formed a Golden Cross for the first time since October 2025

The last one sent prices higher by 10% over the next 10 weeks Source: Barchart

10 Jul 2026

Massive Reversal in Asian Markets

Over $500 BILLION has been added to Asian stocks today as semiconductor and AI stocks rebounded after the recent sell-off, following a strong close on U.S. stocks. South Korea's KOSPI is up +4.6%, adding ₩280.6 trillion ($189B). Japan's NIKKEI is up +1.6%, adding ¥22.9 trillion ($139B). Taiwan is up +1.2%, adding NT4.1 trillion ($50B). China's SSE is up +0.8%, adding ¥520 billion ($73B). Hong Kong's HSI is up +1.5%, adding HK$131.6 billion ($17B). India's NIFTY is up +1.0%, adding ₹4.9 trillion ($57B). Source: Bull Theory

10 Jul 2026

To put things into perspective: The Nasdaq 100 is currently trading at ~23x NTM P/E

which is broadly inline with its 10y average multiple and towards the lower end of its 3-4y range, Goldman says, Source: HolgerZ, Bloomberg

10 Jul 2026

Of the 20 top performing stocks in the first half (nearly all tech), only two are up so far in Q3, and the average QTD decline is 17%.

Source: Bespoke @bespokeinvest

10 Jul 2026

Someone just filed for a Nasdaq 100 and S&P 500 that owns everyone EXCEPT Elon Musk owned companies.

Source: Evan on X

9 Jul 2026

"A generational transfer in free cash flow is taking place"

- BofA Source: zerohedge

9 Jul 2026

As somewhat of a rarity this decade, small caps (Russell 2000) are outperforming large caps (S&P 500) so far in 2026.

If sustained to the end of the year, it would end 5-years of consecutive annual outperformance by large caps. Source: Koyfin

9 Jul 2026

Biotech bull

After enduring a 62% collapse, biotech has come roaring back. A combination of M&A optimism and positive clinical news has propelled XBI 156% off its 2023 lows, putting the ETF within touching distance of its 2021 highs. Source: TME

Thinking out loud

Sign up for our weekly email highlighting the most popular posts.

Follow us

Thinking out loud

Investing with intelligence

Our latest research, commentary and market outlooks